Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments that treat this condition

Research

Researchers at Mayo Clinic coined the term monoclonal gammopathy of undetermined significance (MGUS). They have been studying the disorder for decades.

The focus is on finding risk factors for getting the condition, how these risk factors might affect treatment, and how to prevent MGUS from leading to blood cancers and other conditions.

Doctors and scientists in the Hematologic Malignancies Program of the Mayo Clinic Comprehensive Cancer Center are working on improving the diagnosis and treatment of myeloma and other blood disorders.

Publications

See a list of publications on monoclonal gammopathy of undetermined significance (MGUS) by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

Sept. 10, 2024

Living with monoclonal gammopathy of undetermined significance (mgus)?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

naiviv
Immune Thrombocytopenia Purpura (ITP): What helps?

165 Replies Thu, Nov 07, 2024

beanglow
What was your experience with bone marrow biopsy?

138 Replies Wed, Nov 06, 2024

Lori, Volunteer Mentor
My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

539 Replies Wed, Nov 06, 2024

See more discussions

Related

Associated Procedures

Products & Services

Monoclonal gammopathy of undetermined significance (MGUS)